Pharming Group NV (PHAR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

Pharming Group NV released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 97.29 M (forecast USD 90.39 M) and actual EPS of USD 0.1502 (forecast USD 0.0045)

04:00

Pharming Group NV released FY2025 9 Months Earnings on November 6, 2025 (EST), with actual revenue of USD 269.6 M and EPS of USD -0.0034

04:00

Oct29

Pharming Group NV to Release FY2025 Q3 Earnings on November 5, 2025 (EST), Forecast Revenue USD 91.6 M, EPS USD 0.0045

00:08

Aug1

Pharming Group NV released FY2025 Semi-Annual Earnings on July 31 (EST), actual revenue USD 172.32 M, actual EPS USD -0.15 (forecast EPS USD -0.032)

03:00

Pharming Group NV released FY2025 Q2 earnings on July 31 (EST), actual revenue USD 0 (forecast USD 82.36 M), actual EPS USD 0 (forecast USD -0.0125)

03:00

Jul23

Pharming Group NV to release FY2025 Q2 earnings on July 30, 2025 (EST), forecast revenue USD 82.36 M, EPS USD -0.0125

00:08

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 97.29 M, Net Income 7.548 M, EPS 0.1502

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 93.22 M, Net Income 4.694 M, EPS 0.0663

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 79.09 M, Net Income -14.72 M, EPS -0.22

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More